Mutations in the protease gene associated with virological failure to lopinavir-containing regimens in clinical samples
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-2652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Mutations in the protease gene associated with virological failure to lopinavir-containing regimens in clinical samples ; volume:11 ; number:1 ; day:10 ; month:11 ; year:2008 ; pages:1 ; date:12.2008
Journal of the International AIDS Society / International AIDS Society ; 11, Heft 1 (10.11.2008), 1, 12.2008
- Creator
-
Santos, JR
- Contributor
-
Llibre, JM
Pérez-Álvarez, N.
Domingo, P.
Miralles, C.
Schapiro, J.
Clotet, B.
SpringerLink (Online service)
- DOI
-
10.1186/1758-2652-11-S1-P191
- URN
-
urn:nbn:de:1111-2016052054598
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Santos, JR
- Llibre, JM
- Pérez-Álvarez, N.
- Domingo, P.
- Miralles, C.
- Schapiro, J.
- Clotet, B.
- SpringerLink (Online service)
Other Objects (12)
Virological and immunological response to three boosted protease inhibitor regimens
Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children
Relating protease inhibitor resistance at time of virological failure with drug exposure
Sustained virological response 12 versus sustained virological response 24 as evaluation endpoints in chronic hepatitis C virus Egyptian patients treated with sofosbuvir-based regimens
Virological failure and predictors in patients with clinical and immunological failures to first-line ARV regimens in Vietnam
Suitability of different diagnostic platforms for virological testing of blood samples from cornea donors
Suitability of different diagnostic platforms for virological testing of blood samples from cornea donors
Suitability of Different Diagnostic Platforms for Virological Testing of Blood Samples from Cornea Donors
Alternative methods to analyse the impact of HIV mutations on virological response to antiviral therapy
Prevalence of resistance and HIV-1 protease mutation patterns after failures with fosamprenavir-containing regimens
Lipometabolic side-effects of three ritonavir-boosted double protease inhibitor regimens without reverse transcriptase inhibitors
Pre-treatment minority HIV-1 drug resistance mutations and long term virological outcomes: is prediction possible?
Virological and immunological response to three boosted protease inhibitor regimens
Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children
Relating protease inhibitor resistance at time of virological failure with drug exposure
Sustained virological response 12 versus sustained virological response 24 as evaluation endpoints in chronic hepatitis C virus Egyptian patients treated with sofosbuvir-based regimens
Virological failure and predictors in patients with clinical and immunological failures to first-line ARV regimens in Vietnam
Suitability of different diagnostic platforms for virological testing of blood samples from cornea donors
Suitability of different diagnostic platforms for virological testing of blood samples from cornea donors
Suitability of Different Diagnostic Platforms for Virological Testing of Blood Samples from Cornea Donors
Alternative methods to analyse the impact of HIV mutations on virological response to antiviral therapy
Prevalence of resistance and HIV-1 protease mutation patterns after failures with fosamprenavir-containing regimens
Lipometabolic side-effects of three ritonavir-boosted double protease inhibitor regimens without reverse transcriptase inhibitors
Pre-treatment minority HIV-1 drug resistance mutations and long term virological outcomes: is prediction possible?
Virological and immunological response to three boosted protease inhibitor regimens
Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children
Relating protease inhibitor resistance at time of virological failure with drug exposure
Sustained virological response 12 versus sustained virological response 24 as evaluation endpoints in chronic hepatitis C virus Egyptian patients treated with sofosbuvir-based regimens
Virological failure and predictors in patients with clinical and immunological failures to first-line ARV regimens in Vietnam
Suitability of different diagnostic platforms for virological testing of blood samples from cornea donors
Suitability of different diagnostic platforms for virological testing of blood samples from cornea donors
Suitability of Different Diagnostic Platforms for Virological Testing of Blood Samples from Cornea Donors
Alternative methods to analyse the impact of HIV mutations on virological response to antiviral therapy
Prevalence of resistance and HIV-1 protease mutation patterns after failures with fosamprenavir-containing regimens
Lipometabolic side-effects of three ritonavir-boosted double protease inhibitor regimens without reverse transcriptase inhibitors